CHEK2 and breast carcinoma: While this difference may simply reflect a low frequency of CHEK2 mutations in unselected, consecutive patients with breast cancer, previous Chinese and Japanese studies also failed to detect CHEK2 c.1100delC, and showed a low prevalence of other CHEK2 mutations7,16,17,31.